Cisatracurium 10 mg vials recalled after subpotent stability assay results
Somerset Therapeutics is recalling 52,340 vials of Cisatracurium Besylate Injection, 10 mg/5 mL, after out of specification assay results during long term stability testing.
- Product
- CISATRACURIUM BESYLATE — CISATRACURIUM BESYLATE (CISATRACURIUM BESYLATE)
- Category
- Drug
- Distribution
- Distributed nationwide